Skip to content

Content transparency

  • Published:
  • Updated:
  • Editorial record: · no verified named reviewer is attached
  • Sources: 4 references listed
Authorship, review and conflicts
Named author
No verified public author identity is recorded for this page. Dog Tumor is the publisher; no veterinary authorship is implied.
Clinical review
No verified named veterinary or subject-matter reviewer is recorded for this page.
Conflicts
No page-specific conflict statement is recorded. Read the editorial standards.
Directory Entry

Energyvet Imunovet: Veterinary Product Profile

Herbal Formula · Immune-support Supplement · Supplement · Imunovet · Dogs & Cats · After Surgery · Long-term Management
Brand: EnergyvetCommon name: Energyvet ImunovetEditorial source check: Dog Tumor Editorial Team (editorial review; not licensed veterinary review)Last reviewed: Aug 12, 2026Official link: Visit
Directory entry:This page explains what the product, drug, herb, chemotherapy approach, or supportive-care option is. For step-by-step use or monitoring, read related Guides and consult a veterinarian.
Entry kind
Branded product
Product family
Imunovet

Quick summary

Energyvet Imunovet is a named branded product for All animal species according to the manufacturer, including dogs and cats; manufacturer positioning is kept separate from independent clinical and regulatory evidence.

What it is

30 mL liquid intended for oral or topical use according to the current manufacturer material. Intended species: All animal species according to the manufacturer, including dogs and cats.

Active ingredients / formula

The official product information identifies the liquid as 100% Croton lechleri sap or resin, commonly called Dragon's Blood. No additional active botanical is listed on the reviewed product page; the current physical label must establish carrier, preservative, and market-version details if present.

Mechanism / rationale

Energyvet markets Imunovet for immune support, wound care, mucosal support, and adjunctive discussion in serious disease, including cancer-related contexts. The Dragon's Blood name and traditional or biological explanations do not establish an antineoplastic effect in dogs or cats.

How it is discussed in tumor care

May be discussed only as supportive care within a veterinarian-led plan; it must not replace diagnosis, staging, standard treatment, symptom control, or emergency care.

Potential role

Define a modest supportive objective, baseline, review date, adverse-event plan, and stopping rule with the veterinarian.

Typical use context

Bring the current label, lot, full ingredient panel, country version, complete diet, medicines, and supplements to the treating veterinarian.

Evidence snapshot

The official pages establish product identity, ingredient, presentation, routes described by the manufacturer, and broad species. No controlled canine or feline oncology trial of finished Imunovet was identified. Traditional use and laboratory findings concerning Croton lechleri constituents do not demonstrate tumour shrinkage, delayed progression, better treatment tolerance, or survival benefit.

Safety notes

Croton lechleri resin is biologically active and strongly astringent. Oral and topical use create different exposure questions. Review gastrointestinal disease, skin or wound status, allergy, pregnancy, anaesthesia, immune-directed therapy, chemotherapy, and all medicines before use. The current leaflet and physical label control warnings and application; do not apply a nonsterile product to a surgical wound without veterinary direction.

Interactions / cautions

No universal compatibility conclusion is made. Review the complete label and individualized treatment plan with the veterinarian.

Regulatory status

The manufacturer presents Imunovet as a veterinary herbal product for oral and external use in the Czech Republic. An authorisation for this exact name was not identified in the current Czech register of authorised veterinary medicinal products, and no EU oncology-medicine or sterile-wound medicine authorisation was verified. The precise non-medicinal national category and routes should be confirmed from the current label.

Regions, labels and market differences

Czech Republic; European Union

Monitoring plan

Document route, bottle, lot, label, exact application site if topical, and the supportive goal. For oral use, track appetite, drooling, vomiting, stool, abdominal discomfort, and energy. For skin use, track redness, pain, swelling, discharge, licking, and wound healing under veterinary supervision. Objective tumour assessment and prescribed wound or oncology care continue independently.

Questions to ask your veterinarian

  • What exact supportive objective would justify considering Energyvet Imunovet?
  • Does the current physical label match this identity, strength, and country version?
  • Could an ingredient duplicate or interact with the existing medical, dietary, surgical, or oncology plan?
  • Which adverse signs, tests, or treatment changes should trigger a pause?
  • What review date, stopping rule, and objective tumour monitoring plan apply?

Sources and further reading